Thanks to Acurian, A Sponsor Won its Race to Market with a New Class of OIC Drug

Gastroenterology

Opioid-induced Bowel Dysfunction

Opioid-induced constipation (OIC) is projected to hit $2.8 billion by 2022, according to Credence Research (March 2016 report). Growth for this market will come from the introduction of several new drugs, including this sponsor’s compound, which would be the first to market in a new class.

Read More »